Getting the Right Diagnosis: Genetics and Pathology

Confirming a diagnosis of epidermolytic ichthyosis (EI) is a multi-step process that often begins with a clinical suspicion based on the skin’s appearance and is ultimately supported by genetic testing. Because the condition can look very similar to other blistering disorders in newborns, doctors use specialized pathology and genetics to pinpoint the cause.

The Genetic Blueprint: KRT1 vs. KRT10

EI is caused by mutations in the KRT1 or KRT10 genes ^[1]. While both genes lead to skin fragility, the specific gene involved can influence tendencies in how the condition appears:

• KRT1 Mutations: These tend to be more strongly associated with palmoplantar keratoderma (PPK)—a significant thickening of the skin on the palms of the hands and the soles of the feet ^[2].
• KRT10 Mutations: These mutations are associated with a broader range of symptoms, from mild to severe, and individuals are generally less likely to have severe hand and foot involvement compared to those with KRT1 mutations ^[2][3].

Understanding Inheritance and Recurrence Risk

EI is typically inherited in an autosomal dominant pattern ^[1]. This means:

• If a parent has EI: They have a 50% chance of passing the causative genetic variant to each child they have.
• De Novo Variants: In many cases, the mutation is de novo, meaning it occurred for the first time in the child, and neither parent has the generalized condition ^[4]. If both parents are unaffected, their recurrence risk for future pregnancies is generally low.
• Parental Mosaicism: Sometimes, an unaffected parent may have mosaicism, where the mutation exists only in some of their cells ^[5]. This might show up as a localized “birthmark” known as an epidermolytic nevus (a streak of thick or blistered skin) ^[6]. If that mutation is present in their reproductive cells, they can pass a generalized form of EI to their child. Because a negative blood test in a parent cannot completely rule out mosaicism, a genetic counselor is highly recommended to help families understand their specific risks.

The Pathology Report: A “Pattern,” Not a Diagnosis

If your doctor performs a skin biopsy, you may see the term epidermolytic hyperkeratosis (EHK) on the report. It is crucial to understand that EHK is a histologic reaction pattern—it is a description of what the cells look like under a microscope, not a final disease diagnosis ^[7].

The EHK pattern is characterized by a “bubbling” or breakdown of cells in the upper layers of the skin and a significant buildup of keratin ^[8]. This pattern can be seen in generalized EI, but also in localized epidermolytic nevi, superficial epidermolytic ichthyosis (KRT2), and other incidental findings ^[9][6].

Why Early Biopsies Can Be Tricky

In the first week of a baby’s life, a skin biopsy may actually lack the typical EHK pattern entirely, even if the child definitely has EI ^[10]. If a newborn biopsy comes back as “non-diagnostic,” it does not automatically rule out EI; it simply means the characteristic microscopic changes hadn’t developed yet ^[11]. Neonatal blistering biopsies are highly technique-dependent and require experienced dermatopathology teams.

The Role of Genetic Testing

Because pathology can be vague early on, molecular genetic testing (such as a multi-gene panel) is typically the preferred method for confirmation ^[11]. A panel can identify the specific KRT1 or KRT10 mutation. However, genetic testing is not infallible. Panels can sometimes return a “variant of uncertain significance” (VUS), miss deep or low-level mosaic variants, or come back negative despite a strong clinical diagnosis. Results always require careful interpretation by your specialist or a genetic counselor to correlate the DNA findings with the patient’s actual clinical symptoms ^[12].